MSIGHT Trademark

Trademark Overview


On Monday, February 14, 2022, a trademark application was filed for MSIGHT with the United States Patent and Trademark Office. The USPTO has given the MSIGHT trademark a serial number of 79337981. The federal status of this trademark filing is REGISTERED as of Tuesday, August 15, 2023. This trademark is owned by SEBIA. The MSIGHT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of new technology for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing information in medical and scientific research in the field of clinical trials; providing medical and scientific research information in the pharmaceutical field; research and development in the field of pharmaceuticals and biotechnology; providing diagnostic services in the field of multiple myeloma for residual diseases and analysis, evaluation and reporting of the results of such tests to help healthcare professionals determine the clinical diagnosis of a patient, evaluate the effectiveness of treatments prescribed to patients and change future treatments accordingly; scientific and technological services, namely, research and design in the field of cancer monitoring; industrial analysis and research in the field of cancer monitoring; design and development of computer software
msight

General Information


Serial Number79337981
Word MarkMSIGHT
Filing DateMonday, February 14, 2022
Status700 - REGISTERED
Status DateTuesday, August 15, 2023
Registration Number7134990
Registration DateTuesday, August 15, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wording "MSIGHT" where a blood drop appears within the initial "M".
Pseudo MarkM SIGHT
Goods and ServicesDevelopment of new technology for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing information in medical and scientific research in the field of clinical trials; providing medical and scientific research information in the pharmaceutical field; research and development in the field of pharmaceuticals and biotechnology; providing diagnostic services in the field of multiple myeloma for residual diseases and analysis, evaluation and reporting of the results of such tests to help healthcare professionals determine the clinical diagnosis of a patient, evaluate the effectiveness of treatments prescribed to patients and change future treatments accordingly; scientific and technological services, namely, research and design in the field of cancer monitoring; industrial analysis and research in the field of cancer monitoring; design and development of computer software

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 15, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSEBIA
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Party NameSEBIA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Party NameSEBIA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Monday, December 11, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, November 16, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, November 15, 2023FINAL DISPOSITION PROCESSED
Wednesday, November 15, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 15, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 15, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 30, 2023NOTIFICATION PROCESSED BY IB
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 10, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 21, 2023REFUSAL PROCESSED BY IB
Monday, January 30, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, January 30, 2023REFUSAL PROCESSED BY MPU
Friday, December 2, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 1, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 29, 2022ASSIGNED TO EXAMINER
Tuesday, April 19, 2022APPLICATION FILING RECEIPT MAILED
Friday, April 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 14, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB